Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1503/cmaj.120592

Type

Journal article

Journal

CMAJ : Canadian Medical Association Journal

Publication Date

03/2013

Volume

185

Pages

401 - 406

Addresses

Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. r.h.h.groenwold@umcutrecht.nl

Keywords

PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]), Humans, Influenza Vaccines, Mortality, Confidence Intervals, Odds Ratio, Risk Assessment, Epidemiologic Studies, Bias (Epidemiology), Confounding Factors (Epidemiology), Aged, Aged, 80 and over, Netherlands, Female, Male, Influenza, Human